CYP24A1 and Hypercalcemia: Janiec et al. analyzed long-term outcomes in patients with a history of infantile hypercalcemia, both with mutations in CYP24A1 or SLC34A1, and demonstrated that these patients are at an increased risk of developing progressive chronic kidney disease.